PRIMR

PRIMR PRIMR creates simple illustrated videos to educate patients about cancer and clinical trials.

Equip patients to navigate trials with PRIMR’s trusted videos.Accurate, IRB-approved content at their fingertips. 📱📋http...
11/20/2025

Equip patients to navigate trials with PRIMR’s trusted videos.

Accurate, IRB-approved content at their fingertips. 📱📋

https://www.primrmed.com/

11/19/2025

▶️ Hormone therapy works by blocking estrogen or preventing it from attaching to cancer cells, which can slow or stop hormone receptor-positive breast cancer from growing. You could see benefits like lowering the chance of recurrence, but you may also experience menopausal symptoms, bone thinning, or rare risks like blood clots.

Learn more:
https://www.primrmed.com/cancer-education/hormone-therapy-for-breast-cancer

PRIMR transforms content creation into a predictive engagement strategy for sponsors. 🔮📊https://www.primrmed.com/ ...
11/18/2025

PRIMR transforms content creation into a predictive engagement strategy for sponsors. 🔮📊

https://www.primrmed.com/

11/17/2025

🎯 Adding apalutamide in the INNOVATE trial could improve your chances after surgery by helping stop the cancer from spreading and by shrinking any remaining disease on top of standard radiation and hormone therapy.

Learn more. Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/innovate-trial

visuals make clinical trials easy to understand.



Ronald Chen | The University of Kansas Cancer Center | NRG ONCOLOGY

visuals make clinical trials easy to understand.INNOVATE: testing whether apalutamide + standard therapy can improve c...
11/17/2025

visuals make clinical trials easy to understand.

INNOVATE: testing whether apalutamide + standard therapy can improve cure rates for men with node-positive prostate cancer after surgery.

Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/innovate-trial

Dr. Ronald Chen | The University of Kansas Cancer Center | NRG ONCOLOGY

Enhance clinical trial success with PRIMR’s patient-friendly video content.Simplifying trial information for all. 🎥✅http...
11/13/2025

Enhance clinical trial success with PRIMR’s patient-friendly video content.

Simplifying trial information for all. 🎥✅

https://www.primrmed.com/

11/12/2025

▶️ The Oncotype DX test analyzes the genes of your breast cancer to predict how aggressive it is and whether chemotherapy would help. It helps your doctor personalize your treatment so you can avoid unnecessary chemo if your cancer is less likely to return.

Learn more:
https://www.primrmed.com/cancer-education/oncotype-dx-for-breast-cancer

PRIMR empowers sponsors to navigate future engagement challenges in clinical trials. 🔍🌉https://www.primrmed.com/ ...
11/11/2025

PRIMR empowers sponsors to navigate future engagement challenges in clinical trials. 🔍🌉

https://www.primrmed.com/

11/10/2025

🎯 The RadiCaL Study tests whether adding Radium-223 to standard care reduces bone issues like pain or fractures in metastatic kidney cancer. This may offer better control of cancer that has spread to the bones.

makes trials accessible through watch-worthy content.

Learn more. Watch the IRB-approved video below:
https://www.primrmed.com/cancer-clinical-trials/kidney-cancer-trial-the-radical-study



Rana McKay | UC San Diego School of Medicine
Alliance for Clinical Trials in Oncology

makes trials accessible through watch-worthy content.The RadiCaL Study tests whether adding Radium-223 to standard tre...
11/10/2025

makes trials accessible through watch-worthy content.

The RadiCaL Study tests whether adding Radium-223 to standard treatment can reduce bone-related complications in patients with metastatic kidney cancer.

Watch the IRB-approved video below:
https://www.primrmed.com/cancer-clinical-trials/kidney-cancer-trial-the-radical-study



Rana McKay | UC San Diego School of Medicine
Alliance for Clinical Trials in Oncology

Address

Hartford, CT
06117

Website

Alerts

Be the first to know and let us send you an email when PRIMR posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category